IMPACT OF A MULTICOMPONENT PHYSICAL EXERCISE PROGRAM ON THE FUNCTIONAL CAPACITY OF PATIENTS ADMITTED TO AN INTERMEDIATE CARE HOSPITAL. VIVIFRAIL FOR A BETTER VIG-FRAIL.
1 other identifier
interventional
120
1 country
1
Brief Summary
INTRODUCTION Physical exercise in frail individuals has demonstrated benefits in variables such as reduced mortality risk and improved frailty and quality of life. Specifically, the most beneficial type appears to be multicomponent exercise, which includes strength, endurance, balance, and gait training. Within this field, the VIVIFRAIL project is an internationally recognized physical exercise promotion program. OBJECTIVES To analyze the effects of an individualized multicomponent physical exercise program as an effective method for preventing/improving functional status and frailty in individuals admitted to an intermediate care hospital (ICH). To assess whether improvements in functionality/frailty are maintained 3-4 months after discharge and to evaluate the impact of the program on quality of life variables and health indicators at 6 months. METHODOLOGY Design: randomized clinical trial with two groups (control and intervention) and 6 months of follow-up. Study population: adults older than 65 years admitted to an intermediate care hospital (ICH). Inclusion criteria: baseline Barthel Index ≥60, ability to communicate, ambulate, and complete the exercise program. Primary variables: functionality (Short Physical Performance Battery - SPPB) and frailty (Frail-VIG Index). Secondary variables: grip strength, depressive symptoms, fear of falling, mortality, institutionalization, hospital admissions/emergency room and primary care visits, level of physical activity, medications (number, analgesics, opioid use, antidepressants, anxiolytics), and quality of life. Sample size: assuming a 15% loss to follow-up, the final required sample size is 120 patients. Linear mixed-effects models will be used with a significance level of 0.05.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 18, 2026
CompletedFirst Submitted
Initial submission to the registry
May 28, 2026
CompletedFirst Posted
Study publicly available on registry
June 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
ExpectedJune 9, 2026
May 1, 2026
5 months
May 28, 2026
June 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
functionality
functionality (Short Physical Performance Battery - SPPB)
12 weeks
Study Arms (2)
Control group
NO INTERVENTIONParticipants assigned to the control group will follow the usual therapeutic plan and recommendations without individualized physical exercise prescription.
intervention group
OTHERParticipants assigned to the intervention group will receive instruction from the principal investigator and trained physiotherapy staff regarding the VIVIFRAIL multicomponent physical exercise program.
Interventions
The VIVIFRAIL program consists of exercises combining: * strength, * endurance, * balance, * and gait training, adapted to the participant's functional level according to: * SPPB score, * gait speed. Based on these results, an individualized multicomponent exercise program (Programs A, B, C, or D) will be prescribed. The intervention will begin during hospitalization once the patient is clinically stable.
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
Hospital Sant Andreu. Sant Andreu Salut
Manresa, Barcelona, 08240, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2026
First Posted
June 9, 2026
Study Start
February 18, 2026
Primary Completion
August 1, 2026
Study Completion (Estimated)
February 1, 2027
Last Updated
June 9, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
Data obtained through this study may be provided to qualified researchers with academic interest.